Clinical Trials on B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma an
Total 1393 results
-
Jonsson Comprehensive Cancer CenterNational Institutes of Health (NIH)CompletedLymphoma | Lymphoma, Non-Hodgkin | Large B Cell Diffuse LymphomaUnited States, Germany
-
Sun Yat-sen UniversityCompletedDiffuse Large B-cell Lymphoma
-
Sun Yat-sen UniversityUnknownDiffuse Large B Cell LymphomaChina
-
Sun Yat-sen UniversityUnknownDiffuse Large B Cell LymphomaChina
-
Duke UniversityCompletedDiffuse Large B-cell LymphomaUnited States
-
Brown UniversityWithdrawnDiffuse Large B Cell LymphomaUnited States
-
Henan Cancer HospitalUnknownDiffuse Large B-cell LymphomaChina
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cell LymphomaItaly
-
Ruijin HospitalUnknown
-
Lund University HospitalValcuriaCompletedDiffuse Large B-cell LymphomaSweden
-
Idera Pharmaceuticals, Inc.CompletedDiffuse Large B Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedDiffuse Large B Cell LymphomaFrance
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaChina, United States, Colombia, Turkey, Spain, Egypt, Canada, Italy, Singapore, Australia, Austria, Czechia, Greece, Israel, Russian Federation, Hong Kong, Thailand, Korea, Republic of, Lebanon, Japan, Poland, Slovakia, Switzerland, G... and more
-
Weill Medical College of Cornell UniversityCelgeneCompletedDiffuse Large B Cell LymphomaUnited States
-
Pusan National University HospitalUnknown
-
Sinocelltech Ltd.Unknown
-
Grupo Español de Linfomas y Transplante Autólogo...CompletedDiffuse Large B-cell LymphomaSpain
-
La Jolla Pharmaceutical CompanyWithdrawnDiffuse Large B-cell LymphomaUnited States
-
Samsung Medical CenterCompletedDiffuse Large B-cell LymphomaKorea, Republic of
-
University of BolognaTerminated
-
Chonnam National University HospitalSamsung Medical Center; Asan Medical Center; Severance HospitalUnknownLymphoma, Large B-cell, DiffuseKorea, Republic of
-
The Alvin and Lois Lapidus Cancer InstituteOrtho Biotech Products, L.P.UnknownLymphoma, Non-Hodgkin | Diffuse Large B Cell LymphomaUnited States
-
Sunnybrook Health Sciences CentreMerck Sharp & Dohme LLC; ImmunoVaccine Technologies, Inc. (IMV Inc.)CompletedRecurrent | Adult Diffuse Large Cell Lymphoma | Adult Refractory Diffuse Large B-Cell LymphomaCanada
-
University of WashingtonNational Cancer Institute (NCI)CompletedGrade 3b Follicular Lymphoma | Stage III Follicular Lymphoma | Composite Lymphoma | Stage I Diffuse Large B-Cell Lymphoma | Stage I Follicular Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage II Follicular Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell Lymphoma and other conditionsUnited States
-
Regeneron PharmaceuticalsAvailableDiffuse Large B-Cell Lymphoma (DLBCL) | Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | B-Cell Non-Hodgkin Lymphoma (NHL) | High-Grade B-Cell Lymphoma (HGBCL)
-
National Cancer Institute (NCI)RecruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | AIDS-Related LymphomaUnited States
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Hoffmann-La RocheCompletedDiffuse Large B-cell Lymphoma | High-Grade B-cell LymphomaUnited States, Spain, Australia, Denmark
-
Telios Pharma, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed/Refractory B Cell Malignancies | Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma | Treatment-Naive B Cell MalignanciesUnited States, Poland, Ukraine, Hungary, Italy, Russian Federation, United Kingdom
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLC; Xynomic Pharmaceuticals, Inc.Active, not recruitingMantle Cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Incyte Biosciences Japan GKRecruitingDiffuse Large B-cell Lymphoma | Non Hodgkins LymphomaJapan
-
Spectrum Pharmaceuticals, IncTerminatedDiffuse Large B-cell Lymphoma | Follicle Center LymphomaUnited States, France, United Kingdom, Ireland, Israel, Belgium, Spain, Netherlands, Australia, Puerto Rico, Canada, Italy, Austria
-
Shandong Provincial HospitalRecruitingMantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsChina
-
Hoffmann-La RocheSerbian Lymphoma GroupCompletedLymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma, Lymphoma, Non Hodgkin, Relapsed or Refractory Diffuse Large B-Cell LymphomaSerbia
-
CTI BioPharmaCompletedDiffuse Large-Cell LymphomaUnited States, Germany, Canada, Italy, France
-
Lymphoma Study AssociationCompletedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Copenhagen University Hospital at HerlevNordic Lymphoma GroupCompletedDiffuse Large-Cell LymphomaDenmark
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Central Nervous System Lymphoma | Mantle Cell Lymphoma (MCL) | Non Hodgkin Lymphoma (NHL)United States
-
University of Alabama at BirminghamNot yet recruitingLymphoma, Follicular | Lymphoma, B-Cell | Diffuse Large B Cell LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyActive, not recruitingDiffuse Large B Cell Lymphoma | Transformed LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 PositiveUnited States
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
Institut Claudius RegaudAstraZenecaActive, not recruitingDiffuse Large B-cell LymphomaFrance
-
Stanford UniversityTerminatedLymphoma, Non-Hodgkin | Diffuse Large B-cell Lymphoma (DLBCL) | Lymphoma, B-cell | Malignant Lymphoma, Non-HodgkinUnited States
-
BioNova Pharmaceuticals (Shanghai) LTD.TerminatedFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaChina
-
Gilead SciencesTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Non-FL Indolent Non-Hodgkin's LymphomaUnited States, Canada
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States